日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies

新型 FOXM1 抑制剂 STL001 可增强人类癌症对广谱癌症疗法的敏感性

Sanjeev Raghuwanshi, Xu Zhang, Zarema Arbieva, Irum Khan, Hisham Mohammed, Z Wang, Alexander Domling, Carlos Jaime Camacho, Andrei L Gartel

Antioxidative Stress Metabolic Pathways in Moderately Active Individuals

中度活跃个体的抗氧化应激代谢途径

Shamma Almuraikhy, Najeha Anwardeen, Asmma Doudin, Maha Sellami, Alexander Domling, Abdelali Agouni, Asmaa A Althani, Mohamed A Elrayess

Design, synthesis and biological evaluation of 1,5-disubstituted α-amino tetrazole derivatives as non-covalent inflammasome-caspase-1 complex inhibitors with potential application against immune and inflammatory disorders

1,5-二取代 α-氨基四唑衍生物的设计、合成和生物学评价,作为非共价炎症小体-caspase-1 复合物抑制剂,具有治疗免疫和炎症疾病的潜在应用价值

Fausta Ulgheri, Pietro Spanu, Francesco Deligia, Giovanni Loriga, Maria Pia Fuggetta, Iris de Haan, Ajay Chandgudge, Matthew Groves, Alexander Domling

Production of "biobetter" glucarpidase variants to improve drug detoxification and antibody directed enzyme prodrug therapy for cancer treatment

生产“biobetter”葡萄糖苷酶变体以改善药物解毒和抗体导向的酶前体药物疗法,用于癌症治疗

Alanod D AlQahtani, Layla Al-Mansoori, Sara S Bashraheel, Fatma B Rashidi, Afrah Al-Yafei, Philip Elsinga, Alexander Domling, Sayed K Goda